Why Did Moderna Stock Crash 17% Despite Positive Cancer Vaccine Results?
Coinpedia ·
The post Why Did Moderna Stock Crash 17% Despite Positive Cancer Vaccine Results? appeared first on Coinpedia Fintech News Moderna stock suffered a sharp panic drop on Thursday, falling 17.57% to close at $202.63 despite promising results from its experimental personalized cancer vaccine. The sell-off followed the early publication of Phase 3 trial data for intismeran autogene, developed in partnership with Merck. The treatment demonstrated a meaningful reduction in melanoma recurrence risk, but investors …
प्रकाशन और स्रोत की जानकारी
- मंच
- NewsTiVi
- स्रोत
- Coinpedia
- प्रकाशन का समय
- 23/10/2026, 9:49:56 am
- देश
- भारत
शीर्षक और सारांश प्रकाशक द्वारा दिए गए हैं। पूरी खबर स्रोत की वेबसाइट पर पढ़ें।
संपर्क: info@newstivi.com